MyAverix Finance
F · Healthcare
CASI PHARMAC. NEW O.N. (ENM)
Biotechnology
CASI PHARMAC. NEW O.N. (ENM) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $20.52M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ENM
CASI PHARMAC. NEW O.N. (ENM) — FAQ
What is CASI PHARMAC. NEW O.N.'s market cap?
CASI PHARMAC. NEW O.N. (ENM) has a reported market cap of $20.52M (data as of 2026-03-29).
What is ENM's P/E ratio?
The price-to-earnings (P/E) ratio for CASI PHARMAC. NEW O.N. (ENM) is 18.00 (data as of 2026-03-29).
Does CASI PHARMAC. NEW O.N. pay a dividend?
Dividend yield is not available in the current snapshot for CASI PHARMAC. NEW O.N. (ENM). Check the MyAverix Finance app for the latest dividend data.
What sector is CASI PHARMAC. NEW O.N. in?
CASI PHARMAC. NEW O.N. (ENM) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ENM listed on?
ENM is listed on F.
What is CASI PHARMAC. NEW O.N.'s net margin?
CASI PHARMAC. NEW O.N. (ENM) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.